May 1, 2019 09:41 AM EDTUpdated 10:43 AM

AbbVie nabs pediatric OK for hep C drug Mavyret; Glenmark launches cheaper SGLT2 inhibitor in India

Amber Tong

→ Building off a surprise success with Mavyret in adults, AbbVie has nabbed an FDA approval to market …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Struggling biotechs succumb to icy market, as money dries up and clinical bets don’t pay off

In a first, Sarepta announces platform technology designation for gene therapy vector

Exclusive: After cutting most staff, Casma eyes path to clinic with its first autophagy-boosting drug

AnaptysBio describes ‘JAK-like’ efficacy for PD-1 drug in rheumatoid arthritis

Lilly makes a move for long-acting incretins in tech deal with Swedish biotech

sponsored

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...